United States Iloprost Market Report 2016

November 2016 | 114 pages | ID: U58E6836AD0EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Iloprost

Revenue, means the sales value of Iloprost

This report studies sales (consumption) of Iloprost in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• Sanofi S.A (France)
• Bayer HealthCare Pharmaceuticals (Germany)
• Actelion Pharmaceuticals Ltd. (Switzerland)
• Daiichi Sankyo Co., Ltd. (Japan)
• Eli Lilly and Company (US)
• YM BioSciences, Inc. (Canada)
• GlaxoSmithKline Plc (UK)
• Nippon Shinyaku Co., Ltd. (Japan)
• Cipla Limited (India)
• Arena Pharmaceuticals, Inc. (US)
• The Novartis Group (Switzerland)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Iloprost in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Iloprost Market Report 2016

1 ILOPROST OVERVIEW

1.1 Product Overview and Scope of Iloprost
1.2 Classification of Iloprost
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Iloprost
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Iloprost (2011-2021)
  1.4.1 United States Iloprost Sales and Growth Rate (2011-2021)
  1.4.2 United States Iloprost Revenue and Growth Rate (2011-2021)

2 UNITED STATES ILOPROST COMPETITION BY MANUFACTURERS

2.1 United States Iloprost Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Iloprost Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Iloprost Average Price by Manufactures (2015 and 2016)
2.4 Iloprost Market Competitive Situation and Trends
  2.4.1 Iloprost Market Concentration Rate
  2.4.2 Iloprost Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ILOPROST SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Iloprost Sales and Market Share by Type (2011-2016)
3.2 United States Iloprost Revenue and Market Share by Type (2011-2016)
3.3 United States Iloprost Price by Type (2011-2016)
3.4 United States Iloprost Sales Growth Rate by Type (2011-2016)

4 UNITED STATES ILOPROST SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Iloprost Sales and Market Share by Application (2011-2016)
4.2 United States Iloprost Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES ILOPROST MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Iloprost Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Sanofi S.A (France)
  5.2.2 Iloprost Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Sanofi S.A (France) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Bayer HealthCare Pharmaceuticals (Germany)
  5.3.2 Iloprost Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Bayer HealthCare Pharmaceuticals (Germany) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Actelion Pharmaceuticals Ltd. (Switzerland)
  5.4.2 Iloprost Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Actelion Pharmaceuticals Ltd. (Switzerland) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Daiichi Sankyo Co., Ltd. (Japan)
  5.5.2 Iloprost Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Daiichi Sankyo Co., Ltd. (Japan) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Eli Lilly and Company (US)
  5.6.2 Iloprost Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Eli Lilly and Company (US) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 YM BioSciences, Inc. (Canada)
  5.7.2 Iloprost Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 YM BioSciences, Inc. (Canada) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 GlaxoSmithKline Plc (UK)
  5.8.2 Iloprost Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 GlaxoSmithKline Plc (UK) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Nippon Shinyaku Co., Ltd. (Japan)
  5.9.2 Iloprost Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Nippon Shinyaku Co., Ltd. (Japan) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Cipla Limited (India)
  5.10.2 Iloprost Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Cipla Limited (India) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Arena Pharmaceuticals, Inc. (US)
5.12 The Novartis Group (Switzerland)

6 ILOPROST MANUFACTURING COST ANALYSIS

6.1 Iloprost Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Iloprost

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Iloprost Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Iloprost Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES ILOPROST MARKET FORECAST (2016-2021)

10.1 United States Iloprost Sales, Revenue Forecast (2016-2021)
10.2 United States Iloprost Sales Forecast by Type (2016-2021)
10.3 United States Iloprost Sales Forecast by Application (2016-2021)
10.4 Iloprost Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Iloprost
Table Classification of Iloprost
Figure United States Sales Market Share of Iloprost by Type in 2015
Table Application of Iloprost
Figure United States Sales Market Share of Iloprost by Application in 2015
Figure United States Iloprost Sales and Growth Rate (2011-2021)
Figure United States Iloprost Revenue and Growth Rate (2011-2021)
Table United States Iloprost Sales of Key Manufacturers (2015 and 2016)
Table United States Iloprost Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Iloprost Sales Share by Manufacturers
Figure 2016 Iloprost Sales Share by Manufacturers
Table United States Iloprost Revenue by Manufacturers (2015 and 2016)
Table United States Iloprost Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Iloprost Revenue Share by Manufacturers
Table 2016 United States Iloprost Revenue Share by Manufacturers
Table United States Market Iloprost Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Iloprost Average Price of Key Manufacturers in 2015
Figure Iloprost Market Share of Top 3 Manufacturers
Figure Iloprost Market Share of Top 5 Manufacturers
Table United States Iloprost Sales by Type (2011-2016)
Table United States Iloprost Sales Share by Type (2011-2016)
Figure United States Iloprost Sales Market Share by Type in 2015
Table United States Iloprost Revenue and Market Share by Type (2011-2016)
Table United States Iloprost Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Iloprost by Type (2011-2016)
Table United States Iloprost Price by Type (2011-2016)
Figure United States Iloprost Sales Growth Rate by Type (2011-2016)
Table United States Iloprost Sales by Application (2011-2016)
Table United States Iloprost Sales Market Share by Application (2011-2016)
Figure United States Iloprost Sales Market Share by Application in 2015
Table United States Iloprost Sales Growth Rate by Application (2011-2016)
Figure United States Iloprost Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Iloprost Sales Market Share (2011-2016)
Table Sanofi S.A (France) Basic Information List
Table Sanofi S.A (France) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A (France) Iloprost Sales Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Basic Information List
Table Bayer HealthCare Pharmaceuticals (Germany) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Iloprost Sales Market Share (2011-2016)
Table Actelion Pharmaceuticals Ltd. (Switzerland) Basic Information List
Table Actelion Pharmaceuticals Ltd. (Switzerland) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table Actelion Pharmaceuticals Ltd. (Switzerland) Iloprost Sales Market Share (2011-2016)
Table Daiichi Sankyo Co., Ltd. (Japan) Basic Information List
Table Daiichi Sankyo Co., Ltd. (Japan) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daiichi Sankyo Co., Ltd. (Japan) Iloprost Sales Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company (US) Iloprost Sales Market Share (2011-2016)
Table YM BioSciences, Inc. (Canada) Basic Information List
Table YM BioSciences, Inc. (Canada) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table YM BioSciences, Inc. (Canada) Iloprost Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Iloprost Sales Market Share (2011-2016)
Table Nippon Shinyaku Co., Ltd. (Japan) Basic Information List
Table Nippon Shinyaku Co., Ltd. (Japan) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nippon Shinyaku Co., Ltd. (Japan) Iloprost Sales Market Share (2011-2016)
Table Cipla Limited (India) Basic Information List
Table Cipla Limited (India) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cipla Limited (India) Iloprost Sales Market Share (2011-2016)
Table Arena Pharmaceuticals, Inc. (US) Basic Information List
Table Arena Pharmaceuticals, Inc. (US) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arena Pharmaceuticals, Inc. (US) Iloprost Sales Market Share (2011-2016)
Table The Novartis Group (Switzerland) Basic Information List
Table The Novartis Group (Switzerland) Iloprost Sales, Revenue, Price and Gross Margin (2011-2016)
Table The Novartis Group (Switzerland) Iloprost Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Iloprost
Figure Manufacturing Process Analysis of Iloprost
Figure Iloprost Industrial Chain Analysis
Table Raw Materials Sources of Iloprost Major Manufacturers in 2015
Table Major Buyers of Iloprost
Table Distributors/Traders List
Figure United States Iloprost Production and Growth Rate Forecast (2016-2021)
Figure United States Iloprost Revenue and Growth Rate Forecast (2016-2021)
Table United States Iloprost Production Forecast by Type (2016-2021)
Table United States Iloprost Consumption Forecast by Application (2016-2021)